295 related articles for article (PubMed ID: 23748016)
1. BDNF Val66Met variants and brain volume changes in non-affective psychosis patients and healthy controls: a 3 year follow-up study.
Suárez-Pinilla P; Roiz-Santiáñez R; de la Foz VO; Mata I; Fañanas L; Brambilla P; Ruíz-Pérez E; Crespo-Facorro B
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():201-6. PubMed ID: 23748016
[TBL] [Abstract][Full Text] [Related]
2. Hippocampal volume and the brain-derived neurotrophic factor Val66Met polymorphism in first episode psychosis.
Smith GN; Thornton AE; Lang DJ; Macewan GW; Ehmann TS; Kopala LC; Tee K; Shiau G; Voineskos AN; Kennedy JL; Honer WG
Schizophr Res; 2012 Feb; 134(2-3):253-9. PubMed ID: 22192502
[TBL] [Abstract][Full Text] [Related]
3. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
[TBL] [Abstract][Full Text] [Related]
4. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
[TBL] [Abstract][Full Text] [Related]
5. BDNF val66met modulates the association between childhood trauma, cognitive and brain abnormalities in psychoses.
Aas M; Haukvik UK; Djurovic S; Bergmann Ø; Athanasiu L; Tesli MS; Hellvin T; Steen NE; Agartz I; Lorentzen S; Sundet K; Andreassen OA; Melle I
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():181-8. PubMed ID: 23876786
[TBL] [Abstract][Full Text] [Related]
6. Influence of BDNF and MTHFR polymorphisms on hippocampal volume in first-episode psychosis.
Pujol N; Mané A; Bergé D; Mezquida G; Amoretti S; Pérez L; González-Pinto A; Barcones F; Cuesta MJ; Sánchez-Tomico G; Vieta E; Castro-Fornieles J; Bernardo M; Parellada M;
Schizophr Res; 2020 Sep; 223():345-352. PubMed ID: 32988741
[TBL] [Abstract][Full Text] [Related]
7. BDNF serum concentrations in first psychotic episode drug-naïve schizophrenic patients: associations with personality and BDNF Val66Met polymorphism.
Sotiropoulou M; Mantas C; Bozidis P; Marselos M; Mavreas V; Hyphantis T; Antoniou K
Life Sci; 2013 Mar; 92(4-5):305-10. PubMed ID: 23333821
[TBL] [Abstract][Full Text] [Related]
8. BDNF gene polymorphism, cognition and symptom severity in a Brazilian population-based sample of first-episode psychosis subjects.
Martinho E; Michelon L; Ayres AM; Scazufca M; Menezes PR; Schaufelberger MS; Murray RM; Rushe TM; Vallada H; Busatto Filho G
Braz J Psychiatry; 2012 Oct; 34 Suppl 2():S219-25. PubMed ID: 23429848
[TBL] [Abstract][Full Text] [Related]
9. Childhood trauma, BDNF Val66Met and subclinical psychotic experiences. Attempt at replication in two independent samples.
de Castro-Catala M; van Nierop M; Barrantes-Vidal N; Cristóbal-Narváez P; Sheinbaum T; Kwapil TR; Peña E; Jacobs N; Derom C; Thiery E; van Os J; van Winkel R; Rosa A
J Psychiatr Res; 2016 Dec; 83():121-129. PubMed ID: 27596955
[TBL] [Abstract][Full Text] [Related]
10. [Association study of brain-derived neurotrophic factor Val66Met polymorphism and clinical characteristics of first episode schizophrenia].
Sun MM; Liu LF; Yang LM; Wang Y; Cui KY; Wang LN; Li CL; Qiao DD; Wang RZ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):155-8. PubMed ID: 22487823
[TBL] [Abstract][Full Text] [Related]
11. BDNF Val66Met polymorphism and brain volumes in multiple sclerosis.
Dinacci D; Tessitore A; Russo A; De Bonis ML; Lavorgna L; Picconi O; Sacco R; Bonavita S; Gallo A; Servillo G; Marcuccio L; Comerci M; Galletti P; Alfano B; Tedeschi G
Neurol Sci; 2011 Feb; 32(1):117-23. PubMed ID: 20953813
[TBL] [Abstract][Full Text] [Related]
12. Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia.
Koolschijn PC; van Haren NE; Bakker SC; Hoogendoorn ML; Hulshoff Pol HE; Kahn RS
Hippocampus; 2010 Sep; 20(9):1010-7. PubMed ID: 19714565
[TBL] [Abstract][Full Text] [Related]
13. Association of the brain-derived neurotrophic factor Val66Met polymorphism with negative symptoms severity, but not cognitive function, in first-episode schizophrenia spectrum disorders.
Mezquida G; Penadés R; Cabrera B; Savulich G; Lobo A; González-Pinto A; Penzol MJ; Corripio I; Fernandez-Egea E; Gassó P; Cuesta MJ; Bernardo M;
Eur Psychiatry; 2016 Oct; 38():61-69. PubMed ID: 27668551
[TBL] [Abstract][Full Text] [Related]
14. Is BDNF-Val66Met polymorphism associated with psychotic experiences and psychotic disorder outcome? Evidence from a 6 years prospective population-based cohort study.
Kirli U; Binbay T; Drukker M; Elbi H; Kayahan B; Gökçelli DK; Özkınay F; Onay H; Alptekin K; van Os J
Am J Med Genet B Neuropsychiatr Genet; 2019 Mar; 180(2):113-121. PubMed ID: 29785763
[TBL] [Abstract][Full Text] [Related]
15. Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.
Hashim HM; Fawzy N; Fawzi MM; Karam RA
J Psychiatr Res; 2012 Jun; 46(6):762-6. PubMed ID: 22521161
[TBL] [Abstract][Full Text] [Related]
16. Impact on the Onset of Psychosis of a Polygenic Schizophrenia-Related Risk Score and Changes in White Matter Volume.
Harrisberger F; Smieskova R; Egli T; Simon AE; Riecher-Rössler A; Fusar-Poli P; Papassotiropoulos A; Borgwardt S
Cell Physiol Biochem; 2018; 48(3):1201-1214. PubMed ID: 30045020
[TBL] [Abstract][Full Text] [Related]
17. Brain-derived neurotrophic factor genotype is associated with brain gray and white matter tissue volumes recovery in abstinent alcohol-dependent individuals.
Mon A; Durazzo TC; Gazdzinski S; Hutchison KE; Pennington D; Meyerhoff DJ
Genes Brain Behav; 2013 Feb; 12(1):98-107. PubMed ID: 22989210
[TBL] [Abstract][Full Text] [Related]
18. Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor.
Zivadinov R; Weinstock-Guttman B; Benedict R; Tamaño-Blanco M; Hussein S; Abdelrahman N; Durfee J; Ramanathan M
Hum Mol Genet; 2007 Nov; 16(22):2659-68. PubMed ID: 17656372
[TBL] [Abstract][Full Text] [Related]
19. Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia.
Ho BC; Andreasen NC; Dawson JD; Wassink TH
Am J Psychiatry; 2007 Dec; 164(12):1890-9. PubMed ID: 18056245
[TBL] [Abstract][Full Text] [Related]
20. Effects of the BDNF Val66Met Polymorphism on Gray Matter Volume in Typically Developing Children and Adolescents.
Hashimoto T; Fukui K; Takeuchi H; Yokota S; Kikuchi Y; Tomita H; Taki Y; Kawashima R
Cereb Cortex; 2016 Apr; 26(4):1795-803. PubMed ID: 26830347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
